Publications by authors named "K Van Asten"

Claim this Profile
P
Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer.
Kathleen Van Asten, Laurence Slembrouck, Siel Olbrecht, Lynn Jongen, Olivier Brouckaert

Oncologist· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial.
Patrick Neven, Lynn Jongen, Anneleen Lintermans, Kathleen Van Asten, Chantal Blomme

Clin Cancer Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index, age at breast cancer diagnosis, and breast cancer subtype: a cross-sectional study.
O Brouckaert, K Van Asten, A Laenen, A Soubry, A Smeets

Breast Cancer Res Treat· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients.
Matteo Lambertini, Ana Catarina Pinto, Lieveke Ameye, Lynn Jongen, Lucia Del Mastro, Kathleen Van Asten

Br J Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients.
A Lintermans, K Van Asten, L Jongen, T Van Brussel, A Laenen

Eur J Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis